Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Buffet

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
European Thyroid Journal|December 5, 2024
Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytologyWiame Potonnier, Erell Guillerm, Claude Bigorgne, et al.
The Oncologist|December 18, 2015
Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid CarcinomasJohanna Wassermann, Marie-Odile Bernier, Jean-Philippe Spano, et al.
European Thyroid Journal|January 18, 2024
Next-Generation-Sequencing on fine needle aspirates in neck recurrence of thyroid cancersHelene Theodon, Erell Guillerm, Johanna Wassermann, et al.
Annales D'Endocrinologie|January 16, 2025
Chapter 10: What parathyroid imaging is required for hyperparathyroidism?Benjamin Chevalier, Cécile Ghander, Miriam Ladsous, et al.
Plos One|September 15, 2017
DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancersCamille Buffet, Karine Hecale-Perlemoine, Léopoldine Bricaire, et al.
JMIR Research Protocols|July 22, 2022
Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)Clémence Baudin, Charlotte Lussey-Lepoutre, Alice Bressand, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 2017
Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life PracticeAmandine Berdelou, Isabelle Borget, Yann Godbert, et al.
Journal of Clinical Medicine|June 2, 2021
Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature ReviewHélène Vergneault, Alexandre Terré, David Buob, et al.
Endocrine|July 9, 2020
Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC studyStéphane Bardet, Nicolas Goardon, Justine Lequesne, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 22, 2024
Health-related quality of life and radioiodine therapy in thyroid cancer patients: a before-and-after studyAlix Legrand, Marie-Odile Bernier, Alice Bressand, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
European Thyroid Journal|December 5, 2024
Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytologyWiame Potonnier, Erell Guillerm, Claude Bigorgne, et al.
The Oncologist|December 18, 2015
Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid CarcinomasJohanna Wassermann, Marie-Odile Bernier, Jean-Philippe Spano, et al.
European Thyroid Journal|January 18, 2024
Next-Generation-Sequencing on fine needle aspirates in neck recurrence of thyroid cancersHelene Theodon, Erell Guillerm, Johanna Wassermann, et al.
Annales D'Endocrinologie|January 16, 2025
Chapter 10: What parathyroid imaging is required for hyperparathyroidism?Benjamin Chevalier, Cécile Ghander, Miriam Ladsous, et al.
Plos One|September 15, 2017
DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancersCamille Buffet, Karine Hecale-Perlemoine, Léopoldine Bricaire, et al.
JMIR Research Protocols|July 22, 2022
Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)Clémence Baudin, Charlotte Lussey-Lepoutre, Alice Bressand, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 2017
Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life PracticeAmandine Berdelou, Isabelle Borget, Yann Godbert, et al.
Journal of Clinical Medicine|June 2, 2021
Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature ReviewHélène Vergneault, Alexandre Terré, David Buob, et al.
Endocrine|July 9, 2020
Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC studyStéphane Bardet, Nicolas Goardon, Justine Lequesne, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 22, 2024
Health-related quality of life and radioiodine therapy in thyroid cancer patients: a before-and-after studyAlix Legrand, Marie-Odile Bernier, Alice Bressand, et al.
Pageof 9